Literature DB >> 32525002

Cathelicidin-BF attenuate kidney injury through inhibiting oxidative stress, inflammation and fibrosis in streptozotocin-induced diabetic rats.

Yuan Liu1, Danhua Kou2, Naying Chu1, Guangjun Ding3.   

Abstract

OBJECTIVE: To investigate protective efficacies and mechanisms of Cathelicidin-BF (BF-30) peptide on streptozotocin (STZ)-induced diabetic kidney injury.
METHODS: Effects of BF-30 on hydrogen peroxide induced oxidative damage in HK-2 renal cells were assessed by CCK-8 method. Forty STZ-induced diabetic rats with kidney injury were randomly divided into model control group, BF-30 group at different doses (0.1, 0.3 and 0.9 mg/kg). Blood biochemical and kidney related indexes as well adrenal morphological changes, inflammation related markers of diabetic rats were measured.
RESULTS: Cell viability of HK-2 cells with oxidative damage induced by hydrogen peroxide were significantly improved by BF-30 with 0.8 μg/mL for 56.5% and 1.6 μg/mL for 82.3% compared with control. Moreover, the decreased reactive oxygen species (ROS), and increased intracellular antioxidant enzymes GPX1, SOD2 and GSH were showed in BF-30 treated groups. In addition, co-incubation of BF-30 in HK-2 cells promoted the increase of p-AMPK and LC3, decreased activation of p-mTOR, BAX and Caspase 3. Chronic treatment of BF-30 improved the STZ-induced diabetic characteristics of diabetic kidney disease (DKD) model rats. Further renal histopathological examination revealed 12-week treatment of BF-30 effectively improved the morphology of nephropathy in DKD rats. Moreover, BF-30 also could ameliorate excessive oxidative stress, renal cell apoptosis and fibrosis, thereby protects renal tissues.
CONCLUSION: BF-30 exerted protective effects on STZ-induced kidney injury mainly through the inhibiting oxidative stress in kidney tissue, reducing renal fibrosis, increasing autophagy, and reducing the renal cell apoptosis related proteins to decrease the cell damage and protect nephrocytes.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  AMPK pathway; Autophagy; Cathelicidin-BF; Diabetic kidney injury; Fibrosis; Streptozotocin

Year:  2020        PMID: 32525002     DOI: 10.1016/j.lfs.2020.117918

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

Review 1.  Magnesium in renal fibrosis.

Authors:  Mengtuan Long; Xiaoyu Zhu; Xuejiao Wei; Dan Zhao; Lili Jiang; Chenhao Li; Die Jin; Changxiu Miao; Yujun Du
Journal:  Int Urol Nephrol       Date:  2022-01-20       Impact factor: 2.266

Review 2.  The critical role of dysregulated autophagy in the progression of diabetic kidney disease.

Authors:  Ziwei Zhang; Yuting Sun; Jiaojiao Xue; Xiangyan Li; Daqing Zhao; Fengmei Lian; Wenxiu Qi; Xiaolin Tong
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

3.  Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease.

Authors:  Qing Fang; Binjie Zheng; Na Liu; Jinfeng Liu; Wenhui Liu; Xinyi Huang; Xiangchang Zeng; Lulu Chen; Zhenyu Li; Dongsheng Ouyang
Journal:  Front Physiol       Date:  2021-06-16       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.